A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults
Stopped The trial was prematurely terminated on 01April2014 due to safety concerns.
Conditions
Interventions
- DRUG: PF-05180999
- DRUG: Placebo
- DRUG: 120 mg MR PF-05180999
- DRUG: 360 mg MR PF-05180999
- DRUG: 10 mg cetirizine
- DRUG: Placebo
Sponsor
Pfizer